09/11/23 4:05 PMNYSE : PRGO Perrigo Announces Leadership UpdatePerrigo Company plc, a leading provider of Consumer Self-Care Products, today announced the appointment of Catherine "Triona" Schmelter as Executive...RHEA-AIneutral
08/24/23 9:41 AMNYSE : PRGO conferencesPerrigo to Attend Upcoming Consumer Investor ConferencesPerrigo Company plc, a leading provider of Consumer Self-Care Products, today announced that CFO Eduardo Bezerra is scheduled to participate in one-on-one investor meetings at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7 th, 2023.. Separately, President and CEO, Patrick...RHEA-AIneutral
08/08/23 6:30 AMNYSE : PRGO earningsPerrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing OperationsSecond quarter net sales of $1.2 billion grew 6.4%, or 6.6% on a constant currency 1 basis, versus the prior year quarter. Non-GAAP gross margin was 38.7%, a 220 basis points improvement compared to the prior year quarter, and a 120 basis points improvement sequentially compared to the first quarter of 2023. Second quarter reported earnings per share was $0.06,...RHEA-AIneutral
08/02/23 10:19 AMNYSE : PRGO dividendsPERRIGO ANNOUNCES QUARTERLY DIVIDENDPerrigo Company plc, a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.273 per share, payable on September 19, 2023, to shareholders of record on September 1, 2023.. Perrigo Company, plc is a leading provider of Consumer Self Care...RHEA-AIneutral
07/25/23 9:31 AMNYSE : PRGO earningsPerrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth ConferencePerrigo Company plc, a leading provider of Consumer Self-Care Products, today announced that it plans to issue its second quarter 2023 financial results on Tuesday, August 8, 2023, and will host a conference call beginning at 8:30 A.M.. Separately, President and CEO, Patrick Lockwood-Taylor and CFO Eduardo Bezerra are...RHEA-AIneutral
07/13/23 8:38 AMNYSE : PRGO fda approvalPerrigo Announces U.S. FDA Approval for Opill® OTC Daily Oral ContraceptivePerrigo Company plc, a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration approved Opill ®, a progestin-only daily oral contraceptive, for over-the-counter use for all ages. "Today's approval is a groundbreaking expansion for women's health in the U.S., and a significant...RHEA-AIneutral
06/08/23 7:40 AMNYSE : PRGO managementPerrigo Appoints Patrick Lockwood-Taylor as President and CEOPerrigo Company plc, a leading provider of Consumer Self-Care Products, today announced the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.. Lockwood-Taylor joins Perrigo from Bayer AG, where he served a...RHEA-AIneutral
05/24/23 9:09 AMNYSE : PRGO conferencesPerrigo to Host 1x1 Investor Meetings at the 23rd Annual Oppenheimer Consumer Growth & E-Commerce ConferencePerrigo Company plc, a leading provider of Consumer Self-Care Products, today announced that it is scheduled to host 1 x1 investor meetings at the Oppenheimer 23rd Annual Consumer Growth& E-Commerce Conference, being conducted virtually on Tuesday, June 13 th. Perrigo Company plc is a leading provider of Consumer Self-Care...RHEA-AIneutral
05/16/23 11:43 AMNYSE : PRGO COUNTRY STAR MITCHELL TENPENNY AND PREVACID ANNOUNCE "BEAT THE BURN" - A LIVE TIK TOK CONCERT TO SING AWAY STRESSDid you know that stress is a leading cause of frequent heartburn? And for those of you in Nashville, get ready because Prevacid will be popping up around town to give away VIP tickets to attend in-person.RHEA-AIneutral
05/16/23 9:02 AMNYSE : PRGO fda approvalPERRIGO ANNOUNCES U.S. FDA APPROVAL FOR NICOTINE COATED MINT LOZENGEPerrigo Company plc, a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug Administration for Nicotine Coated Mint Lozenges, 2 mg and 4 mg over-the-counter. This product will be marketed under retailer's store brand labels as a comparable offering to...RHEA-AIneutral